2 completed, 1 recruiting, 1 unknown. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow delta inulin: new trials by email Literature Review of delta inulin trials Research Report on delta inulin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human Models of Selective Insulin Resistance: Alpelisib, Part I Alpelisib 300 mg, Placebo, [1-13C] sodium acetate - Insulin Resistance, Prediabetic State | Phase 1 | Recruiting | Columbia University | 32 | 2024-04-24 | 2026-08-24 |
| Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax) Delta-inulin, Dose finding comparison - Ant Sting, Immunotherapy | Phase 1 / Phase 2 | Unknown | Central Adelaide Local Health Network Incorporated | 40 | 2016-10-01 | 2020-08-11 |
| Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine ADVAX, TBC-M4, Placebo - HIV Infections | Phase 1 | Completed | International AIDS Vaccine Initiative | 32 | 2008-11-01 | 2013-02-11 |
| Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults ADVAX - HIV Infection | Phase 1 | Completed | International AIDS Vaccine Initiative | 45 | 2003-12-01 | 2013-02-11 |
HIV Infections (2) · Fatty Liver (1) · Hyperinsulinism (1) · Insulin Resistance (1) · Non-alcoholic Fatty Liver Disease (1) · Obesity (1) · Overweight (1) · Prediabetic State (1)
International AIDS Vaccine Initiative (2) · Central Adelaide Local Health Network Incorporated (1) · Columbia University (1)
United States (2) · Australia (1) · United Kingdom (1)
Brian Gazzard, MD (1) · David Ho, MD (1) · Joshua R Cook, MD, PhD (1) · Michael Keefer, MD (1) · Pravin Hissaria, FRACP FRCPA (1) · Soe Than, MD (1)
K12DK133995 (1), K23DK140614 (1)